Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-04-25 00:00:00 ET · period of report 2024-04-23 · accession 0001415889-24-011522 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-25 | 2024-04-23 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $61.92 | -15.0K | 477.8K | -3% | -$928.8K |
| D | 2024-04-25 | 2024-04-23 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +15.0K | 492.8K | +3% | +$26.9K |
| D | 2024-04-25 | 2024-04-23 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -15.0K | 225 | -99% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-23 | S | D | 15,000 | $61.92 | 477,847 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $61.49 to $62.355. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-04-23 | M | A | 15,000 | $1.79 | 492,847 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-04-23 | M | D | 15,000 | $0.00 | 225 | D | $1.79 · — to 2027-05-17 | 15,000 Common Stock | (F5) Stock Option is fully vested and exercisable. |